SM27-1045
SM27-1045
规格:
货期:
编号:TS210879
品牌:Testobio
| 产品名称： | SM27-1045 |
|---|---|
| 商品货号： | TS210879 |
| Organism： | Mus musculus (B cell); Mus musculus (myeloma), mouse (B cell); mouse (myeloma) |
| Product Format： | frozen |
| Culture Properties： | suspension |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Strain： | Strain: C57BL/6 (B cell); BALB/c (myeloma) |
| Applications： | The antibody reacts with a unique cell marker (EM10) that is expressed on stem and progenitor cells, while being less accessible or absent on more mature cells. |
| Storage Conditions： | liquid nitrogen vapor phase |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Derivation： | Spleen cells were fused with P3X63Ag8.653 mouse myeloma cells. |
| Genes Expressed： | immunoglobulin; monoclonal antibody; against EM10 |
| Cellular Products： | immunoglobulin; monoclonal antibody; against EM10 |
| Comments： | Animals were immunized with CD34 positive, CD38 negative human bone marrow cells. Spleen cells were fused with P3X63Ag8.653 mouse myeloma cells. The antibody reacts with a unique cell marker (EM10) that is expressed on stem and progenitor cells, while being less accessible or absent on more mature cells. |
| Complete Growth Medium： | The base medium for this cell line is ATCC-formulated Iscoves Modified Dulbeccos Medium, Catalog No. 30-2005. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
|
| Subculturing： | Protocol: Cultures can be maintained by the addition of fresh medium or replacement of medium. Alternatively, cultures can be established by centrifugation with subsequent resuspension at 1 to 2 X 10(5) viable cells/ml. Maintain cell density between 1 X 10(5) and 1 X 10(6) viable cells/ml. Medium Renewal: Add fresh medium every 2 to 3 days (depending on cell density) |
| Cryopreservation： | Freeze medium: Iscoves modified Dulbeccos medium, 75%; fetal bovine serum, 20%; DMSO, 5% Storage temperature: liquid nitrogen vapor phase |
| Culture Conditions： | Temperature: 37.0°C |
| Isotype： | IgM; kappa light chain |
| Name of Depositor： | SyStemix, Inc. |
| Deposited As： | mouse (B cell); mouse (myeloma) |
| U.S. Patent Number： | |
| References： | Hill BL, et al. Methods of obtaining compositions enriched for hematopoietic stem cells, antibodies for use therein, compositions derived therefrom and methods of use thereof. US Patent 5,814,440 dated Sep 29 1998 |
首页 >
产品中心
>
微生物培养
>
菌株
>
null
>
SM27-1045
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | SM27-1045 |
|---|---|
| 商品货号： | TS210879 |
| Organism： | Mus musculus (B cell); Mus musculus (myeloma), mouse (B cell); mouse (myeloma) |
| Product Format： | frozen |
| Culture Properties： | suspension |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Strain： | Strain: C57BL/6 (B cell); BALB/c (myeloma) |
| Applications： | The antibody reacts with a unique cell marker (EM10) that is expressed on stem and progenitor cells, while being less accessible or absent on more mature cells. |
| Storage Conditions： | liquid nitrogen vapor phase |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Derivation： | Spleen cells were fused with P3X63Ag8.653 mouse myeloma cells. |
| Genes Expressed： | immunoglobulin; monoclonal antibody; against EM10 |
| Cellular Products： | immunoglobulin; monoclonal antibody; against EM10 |
| Comments： | Animals were immunized with CD34 positive, CD38 negative human bone marrow cells. Spleen cells were fused with P3X63Ag8.653 mouse myeloma cells. The antibody reacts with a unique cell marker (EM10) that is expressed on stem and progenitor cells, while being less accessible or absent on more mature cells. |
| Complete Growth Medium： | The base medium for this cell line is ATCC-formulated Iscoves Modified Dulbeccos Medium, Catalog No. 30-2005. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
|
| Subculturing： | Protocol: Cultures can be maintained by the addition of fresh medium or replacement of medium. Alternatively, cultures can be established by centrifugation with subsequent resuspension at 1 to 2 X 10(5) viable cells/ml. Maintain cell density between 1 X 10(5) and 1 X 10(6) viable cells/ml. Medium Renewal: Add fresh medium every 2 to 3 days (depending on cell density) |
| Cryopreservation： | Freeze medium: Iscoves modified Dulbeccos medium, 75%; fetal bovine serum, 20%; DMSO, 5% Storage temperature: liquid nitrogen vapor phase |
| Culture Conditions： | Temperature: 37.0°C |
| Isotype： | IgM; kappa light chain |
| Name of Depositor： | SyStemix, Inc. |
| Deposited As： | mouse (B cell); mouse (myeloma) |
| U.S. Patent Number： | |
| References： | Hill BL, et al. Methods of obtaining compositions enriched for hematopoietic stem cells, antibodies for use therein, compositions derived therefrom and methods of use thereof. US Patent 5,814,440 dated Sep 29 1998 |
